Shandong Loncom will be participate in the CPHI China Expo.
You are here: Home » News » Shandong Loncom will be participate in the CPHI China Expo.

Shandong Loncom will be participate in the CPHI China Expo.

Views: 0     Author: Site Editor     Publish Time: 2024-06-03      Origin: Site

Inquire

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

We are excited to announce that ShandongLoncom Pharmaceutical Co., Ltd. will be participating in the CPHI China Expo. We warmly welcome our valued partners and industry colleagues to visit us at our booth, E7G79.
This event presents an excellent opportunity for us to showcase our latest products and innovations, and to explore potential business collaborations. We look forward to your visit and to engaging in meaningful discussions.
Thank you for your continued support and partnership.

Shandong Loncom has more than 40kinds of API,like Sorafenib Tosylate ,Lacosamide,Abemaciclib,Vortioxetine Hcl,Daprodustat,Elagolix Sodium,Relugolix,Levosimendan,Parecoxib Sodium,Parecoxib Sodium,Vericiguat,Resmetirom,Finerenone,Revefenacin,Fezolinetant,Daridorexant hydrochlorid,Perampanel,Darolutamide,Osimertinib Mesylate,Linzagolix choline,Niraparib Tosylate,Upadacitinib and  Ilaprazole.

If you have any interested in API or you will visit our booth,please contact us.

Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us